The drug showed an average weight reduction of 22% in overweight and obese patients after 36 weeks, a stark contrast to the 2 ...

The Trump administration is bringing new instability to a sector already grappling with a shaky market as well as threats ...

Dementia remains one of the most pressing public health challenges of our time. Its economic burden exceeds $1 trillion ...

The Hold Steady's Craig Finn is back with a new solo song "People of Substance," from his next album, 'Always Been,' produced by Adam Granduciel.

Despite the havoc it is wreaking on the farm, health officials say the risk of the public getting sick is minimal.

Novo Nordisk stock is paring its year-over-year deficit on positive early stage trial results for the company's new weight ...

Donald Trump returned to the US presidency on January 20 with a flurry of executive orders. This included the designation of ...

Oprah Winfrey recently detailed how taking weight loss drugs shifted her longtime mindset about what she described as “thin ...

A novel GLP-1 and amylin receptor agonist featured a safety profile similar to other incretin-based therapies and conferred a ...

In a large cohort of patients with autoimmune diseases, treatment with biologic disease-modifying antirheumatic drugs was ...

Amycretin could give Novo a buzzy product in an newly competitive obesity market. It works similarly to existing GLP-1 ...

Two new meta-analyses make a case for individualistic approaches to puberty blockers and hormone treatments, driven by ...